P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

Authors :: Brandao, M.
Prisciandaro, E.
Xenophontos, E.
Mariolo, A.
Sadeghi, A.H.
Filippi, A.R.
Levy, A.
Bandura, A.
Caramella, C.
Dickhoff, C.
de Margerie-Mellon, C.
Faivre-Finn, C.
Portik, D.
Sanchez-Lorente, D.
De Ruysscher, D.
Smit, E.
Gobbini, E.
Fadel, E.
Ruffini, E.
Olmetto, E.
Cortiula, F.
Bahce, I.
Houda, I.
Opitz, I.
Naidoo, J.
Edwards, J.
Remon, J.
Benitez, J.C.
Trujillo, J.C.
Derks, J.
Amrane, K.
Hartemink, K.
Stathopoulos, K.
Hendriks, L.
Iglesias, M.
Occhipinti, M.
Guckenberger, M.
Giaj Levra, N.
Girard, N.
Reguart, N.
Mercier, O.
Bironzo, P.
Hofman, P.
Horsleben Petersen, R.
De Angelis, R.
Abgral, R.
Terrisse, S.
Popat, S.
Pierret, T.
Gerriet Blum, T.
Ricardi, U.
Dionisi, V.
Berghmans, T.
Dingemans, A.-M.
Source :: Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11, Number 11 Supplement 1 pS292-S293, 2p
Publication Year :: 2023

Full Text Access

Tools